Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen. Jaryal A, Vikrant S. Clin Nephrol 2022;98:280-287.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jaryal A, Vikrant S. Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen. Clin Nephrol 2022;98:280-287.
PMID: 36282172